RA Capital Management as of Sept. 30, 2011
Portfolio Holdings for RA Capital Management
RA Capital Management holds 22 positions in its portfolio as reported in the September 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Columbia Laboratories | 9.7 | $8.1M | 4.2M | 1.95 | |
OncoGenex Pharmaceuticals | 8.9 | $7.6M | 770k | 9.80 | |
ArthroCare Corporation | 8.7 | $7.3M | 255k | 28.77 | |
Derma Sciences | 7.3 | $6.2M | 796k | 7.79 | |
Pharmasset | 6.8 | $5.7M | 70k | 82.37 | |
ACADIA Pharmaceuticals (ACAD) | 6.7 | $5.7M | 5.3M | 1.08 | |
Inhibitex | 5.7 | $4.8M | 2.0M | 2.46 | |
Alexza Pharmaceuticals | 5.0 | $4.2M | 3.9M | 1.08 | |
Endocyte | 4.9 | $4.2M | 393k | 10.60 | |
Raptor Pharmaceutical | 4.8 | $4.1M | 900k | 4.51 | |
Cardionet | 4.8 | $4.0M | 1.3M | 3.00 | |
Gentium S.p.A. | 4.4 | $3.7M | 611k | 6.10 | |
Enzo Biochem (ENZ) | 4.2 | $3.6M | 1.4M | 2.57 | |
Sequenom Inc Co m | 4.1 | $3.5M | 2.6M | 1.31 | |
Anacor Pharmaceuticals In | 3.1 | $2.6M | 462k | 5.70 | |
Furiex Pharmaceuticals | 2.5 | $2.1M | 146k | 14.23 | |
Anthera Pharmaceuticals | 2.1 | $1.8M | 369k | 4.77 | |
Targacept | 2.0 | $1.7M | 114k | 15.00 | |
Synta Pharmaceuticals | 1.8 | $1.5M | 465k | 3.25 | |
Tearlab Corp | 1.5 | $1.2M | 1.4M | 0.90 | |
Sunesis Pharmaceuticals | 0.6 | $510k | 415k | 1.23 | |
Discovery Laboratories | 0.3 | $256k | 131k | 1.96 |